返回
Progress towards improving blood pressure control
DOI:10.1038/s41581-023-00798-7.png)
摘要
En 中文
Despite the availability of effective therapies, the majority of patients with hypertension have poor blood pressure control. Key advances in 2023 have the potential to lead to better treatment adherence and control of blood pressure as well as providing new understanding of postmenopausal hypertension, which may lead to improved therapies. Inaccurate data from a smart wearable cuffless blood pressure device highlights the need to validate such devices to prevent misleading measurements and realize their potential to provide valuable information on beat-to-beat blood pressure2A single dose of the small-interfering RNA zilebesiran resulted in a decrease in blood pressure that was sustained for 24 weeks3Ten-year follow-up data continue to demonstrate a sustained blood-pressure lowering effect of catheter-based renal denervation in patients with resistant hypertension4,5Among postmenopausal women using oestrogen-only hormone replacement therapy, non-oral oestrogen administered at the lowest dose for the shortest time period was associated with the lowest risk of hypertension7
Keyword:
ASSOCIATION
WOMEN
期刊
N
IF:
39.8
论文数:
2.2K
被引数:
1.9W
机构
引用论文
Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes评估市售无袖带可穿戴设备跟踪血压变化的能力
Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension基于导管的肾脏去神经支配: 抵抗性高血压患者的安全性和血压降低的9年随访数据
HYPERTENSION
IF8.2
Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation
HYPERTENSION
IF8.2
Peripheral Immune Cell Composition is Altered in Women Before and After a Hypertension Diagnosis
HYPERTENSION
IF8.2
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE
HYPERTENSION
IF8.2
Association Between the Route of Administration and Formulation of Estrogen Therapy and Hypertension Risk in Postmenopausal Women: A Prospective Population-Based Study
HYPERTENSION
IF8.2
Sex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring
HYPERTENSION
IF8.2
没有更多内容

